2016-2020 World Clostridium Diagnostic Testing Market: Commercial Labs, Hospitals, Physician Offices, Public Health Labs–Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts
The report presents a detailed analysis of the Clostridium diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Clostridium definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
– Hospitals
– Commercial/Private Labs
– Physician Offices
– Public Health Labs
The report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
I. Introduction
II. Clostridium Worldwide Market and Technology Overview
A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies
III. France: Test Volume and Diagnostics Sales Forecast By Market Segment
IV. Germany: Test Volume and Diagnostics Sales Forecast By Market Segment
V. Italy: Test Volume and Diagnostics Sales Forecast By Market Segment
VI. Japan: Test Volume and Diagnostics Sales Forecast By Market Segment
VII. Spain: Test Volume and Diagnostics Sales Forecast By Market Segment
VIII. UK: Test Volume and Diagnostics Sales Forecast By Market Segment
IX. USA: Test Volume and Diagnostics Sales Forecast By Market Segment
X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac
- Wako
List of Tables
Major Companies Developing or Marketing AIDS Tests
France: Clostridium Test Volume and Diagnostics Sales Forecast By Market Segment
Germany: Clostridium Test Volume and Diagnostics Sales Forecast By Market Segment
Italy: Clostridium Test Volume and Diagnostics Sales Forecast By Market Segment
Japan: Clostridium Test Volume and Diagnostics Sales Forecast By Market Segment
Spain: Clostridium Test Volume and Diagnostics Sales Forecast By Market Segment
U.K.: Clostridium Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A.: Clostridium Test Volume and Diagnostics Sales Forecast By Market Segment
Contains 225 pages and 8 tables